Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity
Open Access
- 4 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 16 (8), 1042-1049
- https://doi.org/10.1038/gt.2009.54
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsPublished by American Society of Hematology ,2008
- Redirecting Specificity of T-Cell Populations For CD19 Using the Sleeping Beauty SystemCancer Research, 2008
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008
- Adoptive Cell Transfer TherapySeminars in Oncology, 2007
- Site-directed transposon integration in human cellsNucleic Acids Research, 2007
- A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian CancerClinical Cancer Research, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 StabilityCancer Research, 2006
- Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vectorNature Biotechnology, 2004
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003